Private equity firms Hellman and Friedman, Bain Capital buy Athenahealth for US$ 17 billion

USA – Private equity firms Bain Capital and Hellman & Friedman have paid US$17 billion for Athenahealth, an electronic health records vendor for physician practices. The investment, which provides electronic health records and physician practice tools, is expected to be completed in the first quarter of 2022, according to the company. It is one of a few companies competing in the highly concentrated EHR market, alongside larger players such as Cerner and privately held Epic Systems. Those competitors gradually eroded Athenahealth’s hospital client base, which usually results in larger and…

Read More

Kimberly-Clark invests US$45m to manufacture Huggies Diapers in Kenya

KENYA – International Diaper Manufacturer, Kimberly-Clark, has signed an KSh5 billion (US$45m) contract deal to kick-start the production of Huggies diapers in a newly established factory in Thika. The firm entered an agreement with a local manufacturer, Sai Pharmaceuticals, to begin manufacturing and distribution of the diapers in the Kenyan market, in a move meant to invest in home-grown solutions Speaking during the announcement of the agreement, Kimberly Clark Business Development Director Middle East and Africa, Kevin Achieng elaborated that the move to manufacture the brand locally was aimed at providing high quality and affordable products for residents in Kenya.…

Read More

GSK & Vir Biotech sign pact with U.S to supply Covid-19 antibody therapy doses worth US$1 billion

USA – The US government has signed contracts worth approximately US$1 billion to secure the antibody-based Covid-19 treatment developed by GlaxoSmithKline (GSK) and Vir Biotechnology, the drug makers have announced. GSK and Vir said in a joint statement that the treatment, branded Xevudy, will be available in the United States by December 17, with the government having the option to purchase additional doses until March 2022. Other public deals for the drug, on the other hand, include 10,000 doses for Canada and up to 220,000 doses for the European Union.…

Read More

Nigeria receives WHO certification to locally manufacture vaccines

NIGERIA – The Nigerian National Agency for Food and Drugs Administration and Control has said the country has been certified by the World Health Organization for the production of vaccines. The agency also stated that the country met the 868 requirements set by the global world health regulatory body. Speaking during the ministerial press briefing on COVID-19 organized by the Ministry of Health in Abuja, the Director General of NAFDAC, Prof. Mojisola Adeyeye, added that the agency was trying to build new facilities in seven states. She said, “I am…

Read More

Oncology chain HealthCare Global raises stake in Suchirayu to become majority owner

INDIA – HealthCare Global Enterprises Limited (HCG), a cancer-focused healthcare services provider, announce that it has acquired a majority stake in Suchirayu Healthcare Solutions, gaining an additional 60.9 percent in private funds. With the transaction HCG has increased its stake increased HCG’s stake in Suchirayu from 17.7 percent to 78.6 percent, the company said in statement. Suchirayu owns a multi-specialty hospital in Hubli with 110 beds and the capacity to expand to 250 beds. HCG has been operating and maintaining the hospital since August 2017 and has the right to…

Read More

Kenya issues mandate to citizens to get fully immunized against Covid-19

KENYA – Kenya will require all those seeking in-person government services to be fully vaccinated against COVID-19 from December 21, a government official said announced. Mutahi Kagwe, Cabinet Secretary for Health told journalists in Nairobi that the strict measures follow a review of the prevailing COVID-19 situation in the country and take into account the need of ensuring the country remains on track in the containment of the disease. “All businesses serving 50 or more people will be required to put up signage requiring proof of vaccination before entry into…

Read More

Covid-19 cases begin to spike in South Africa low vaccinations notwithstanding

SOUTH AFRICA – South African coronavirus cases are beginning to climb; the positivity rate of tests is increasing and an analysis of wastewater shows that the disease is once again becoming more prevalent in some areas. On 20 November, the number of confirmed cases over a 24-hour period rose to 887, the highest since 14 October, and on 21 November, 3.4% of tests returned a positive result, according to government data. If maintained over a seven-day period, that would be the highest proportion of people testing positive since the week…

Read More

ASCENT launches new digital solution for tracking, regulating TB treatment

TANZANIA – The fight against tuberculosis (TB) has received fresh impetus following the rolling out of a latest digital technology. The innovation which is part of Adherence Support Coalition to End TB (ASCENT) employs the use of Digital adherence tools (DAT) which enables the patient giving them more freedom to take the medication when and where it suits them best. Such an innovation brings a more robust way to empower patients to take control of their treatment while simplifying the healthcare workers monitoring task in real-time Speaking during the launch,…

Read More

Boehringer Ingelheim’s Jardiance scores marketing nod in India for additional indication

INDIA – Indian drug regulator, the Drugs Controller General of India (DCGI) has given Boehringer Ingelheim permission to market Jardiance (empagliflozin) in India for an additional indication to reduce heart failure in adults. The approval is based on the additional data indicating that the drug significantly lowers the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure and a low ejection fraction. Heart failure is a common and serious complication of a heart attack that occurs when the heart is unable to pump enough blood…

Read More